{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T20:10:55Z","timestamp":1759176655099,"version":"3.40.5"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.ejps.2017.01.018","type":"journal-article","created":{"date-parts":[[2017,1,16]],"date-time":"2017-01-16T21:03:00Z","timestamp":1484600580000},"page":"163-175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Hyperlipidaemia alone and in combination with acidosis can increase the incidence and severity of statin-induced myotoxicity"],"prefix":"10.1016","volume":"100","author":[{"given":"Dhiaa A.","family":"Taha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atheer","family":"Zgair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong Bong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornelia H.","family":"de Moor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberley D.","family":"Bruce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitchell","family":"Sungelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert H.","family":"Eckel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3136-0933","authenticated-orcid":false,"given":"Pavel","family":"Gershkovich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2017.01.018_bb0005","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10557-005-5686-z","article-title":"Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients-the PRIMO study","volume":"19","author":"Bruckert","year":"2005","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.ejps.2017.01.018_bb0010","first-page":"229","article-title":"Prevention of cardiovascular diseases: role of exercise, dietary interventions, obesity and smoking cessation","volume":"10","author":"Buttar","year":"2005","journal-title":"Exp. Clin. Cardiol."},{"key":"10.1016\/j.ejps.2017.01.018_bb0015","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2165\/11319380-000000000-00000","article-title":"Risk factors and drug interactions predisposing to statin-induced myopathy: implications for risk assessment, prevention and treatment","volume":"33","author":"Chatzizisis","year":"2010","journal-title":"Drug Saf."},{"key":"10.1016\/j.ejps.2017.01.018_bb0020","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0022-2275(20)38520-5","article-title":"Postprandial plasma lipoprotein changes in human subjects of different ages","volume":"29","author":"Cohn","year":"1988","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ejps.2017.01.018_bb0025","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/0026-0495(89)90203-5","article-title":"Role of triglyceride-rich lipoproteins from the liver and intestine in the etiology of postprandial peaks in plasma triglyceride concentration","volume":"38","author":"Cohn","year":"1989","journal-title":"Metabolism"},{"key":"10.1016\/j.ejps.2017.01.018_bb0030","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1681\/ASN.V112369","article-title":"Metabolic alkalosis","volume":"11","author":"Galla","year":"2000","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ejps.2017.01.018_bb0035","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ejps.2005.07.011","article-title":"Uptake of lipophilic drugs by plasma derived isolated chylomicrons: linear correlation with intestinal lymphatic bioavailability","volume":"26","author":"Gershkovich","year":"2005","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2017.01.018_bb0040","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ejps.2007.05.109","article-title":"Effect of a high-fat meal on absorption and disposition of lipophilic compounds: the importance of degree of association with triglyceride-rich lipoproteins","volume":"32","author":"Gershkovich","year":"2007","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2017.01.018_bb0045","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1211\/jpp.61.01.0005","article-title":"The role of molecular physicochemical properties and apolipoproteins in association of drugs with triglyceride-rich lipoproteins: in-silico prediction of uptake by chylomicrons","volume":"61","author":"Gershkovich","year":"2009","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejps.2017.01.018_bb0050","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3109\/00498254.2010.529178","article-title":"The effect of increased lipoprotein levels on the pharmacokinetics of ketoconazole enantiomers in the rat","volume":"41","author":"Hamdy","year":"2011","journal-title":"Xenobiotica"},{"key":"10.1016\/j.ejps.2017.01.018_bb0055","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0165-6147(97)01147-4","article-title":"Hydrophilicity\/lipophilicity: relevance for the pharmacology and clinical effects of HMG-CoA reductase inhibitors","volume":"19","author":"Hamelin","year":"1998","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejps.2017.01.018_bb0060","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1001\/jama.1984.03350080036023","article-title":"High-density lipoprotein metabolism in runners and sedentary men","volume":"252","author":"Herbert","year":"1984","journal-title":"JAMA"},{"key":"10.1016\/j.ejps.2017.01.018_bb0065","first-page":"4736","article-title":"The effect of dietary oils on blood lipids and the risk of ischemic heart disease with special emphasis on olive oil. A literature review","volume":"163","author":"Jespersen","year":"2001","journal-title":"Ugeskr. Laeger"},{"key":"10.1016\/j.ejps.2017.01.018_bb0070","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1211\/146080899128734820","article-title":"Differentiation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors by their relative lipophilicity","volume":"5","author":"Joshi","year":"1999","journal-title":"Pharm. Pharmacol. Commun."},{"key":"10.1016\/j.ejps.2017.01.018_bb0075","doi-asserted-by":"crossref","first-page":"4","DOI":"10.5152\/jaem.2014.27880","article-title":"Acid-base disorders in the emergency department: incidence, etiologies and outcomes","volume":"13","author":"K\u00f6se","year":"2014","journal-title":"JAEM"},{"key":"10.1016\/j.ejps.2017.01.018_bb0080","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1053\/j.ajkd.2005.03.003","article-title":"Metabolic acidosis of CKD: diagnosis, clinical characteristics, and treatment","volume":"45","author":"Kraut","year":"2005","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.ejps.2017.01.018_bb0085","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/jps.2600810303","article-title":"Pharmacokinetics of cyclosporine in bone marrow transplantation: longitudinal characterization of drug in lipoprotein fractions","volume":"81","author":"Luke","year":"1992","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2017.01.018_bb0090","first-page":"1866","article-title":"Extreme metabolic acidosis after presumed intoxication with ethylene glycol","volume":"171","author":"Lundgaard","year":"2009","journal-title":"Ugeskr. Laeger"},{"key":"10.1016\/j.ejps.2017.01.018_bb0095","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s12033-013-9712-2","article-title":"Assessment of reference genes for real-time quantitative PCR gene expression normalization during C2C12 and H9c2 skeletal muscle differentiation","volume":"56","author":"Masilamani","year":"2014","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.ejps.2017.01.018_bb0100","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s11745-998-0298-3","article-title":"Comparison of RRR-\u03b1-and all-rac-\u03b1-tocopherol uptake by permanent rat skeletal muscle myoblasts (L6 cells): effects of exogenous lipoprotein lipase","volume":"33","author":"Nakamura","year":"1998","journal-title":"Lipids"},{"key":"10.1016\/j.ejps.2017.01.018_bb0105","doi-asserted-by":"crossref","first-page":"13129","DOI":"10.1016\/S0021-9258(17)36808-4","article-title":"Cellular differences in lipoprotein lipase-mediated uptake of low-density lipoproteins","volume":"269","author":"Obunike","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejps.2017.01.018_bb0110","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1093\/eurheartj\/ehs092","article-title":"European guidelines on cardiovascular disease prevention in clinical practice (version 2012)","volume":"33","author":"Perk","year":"2012","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ejps.2017.01.018_bb0115","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0924-977X(02)00078-0","article-title":"The influence of dyslipidemia on the plasma protein and lipoprotein distribution of haloperidol","volume":"13","author":"Procyshyn","year":"2003","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.ejps.2017.01.018_bb0120","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/0003-2697(75)90488-1","article-title":"Separation of plasma lipoproteins by density-gradient ultracentrifugation","volume":"65","author":"Redgrave","year":"1975","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejps.2017.01.018_bb0125","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.numecd.2014.05.009","article-title":"Resistance and intolerance to statins","volume":"24","author":"Reiner","year":"2014","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"10.1016\/j.ejps.2017.01.018_bb0130","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1172\/JCI116018","article-title":"Lipoprotein lipase-mediated uptake and degradation of low-density lipoproteins by fibroblasts and macrophages","volume":"90","author":"Rumsey","year":"1992","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejps.2017.01.018_bb0135","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1042\/bj3180015","article-title":"Muscle-specific overexpression of lipoprotein lipase in transgenic mice results in increased \u03b1-tocopherol levels in skeletal muscle","volume":"318","author":"Sattler","year":"1996","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejps.2017.01.018_bb0140","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.cmet.2015.08.002","article-title":"Statin-induced myopathy is associated with mitochondrial complex III inhibition","volume":"22","author":"Schirris","year":"2015","journal-title":"Cell Metab."},{"key":"10.1016\/j.ejps.2017.01.018_bb0145","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1023\/A:1012120104615","article-title":"pH dependent binding of ligands to serum lipoproteins","volume":"14","author":"Simon","year":"1997","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2017.01.018_bb0150","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1365-2125.2003.02044.x","article-title":"Professional athletes suffering from familial hypercholesterolaemia rarely tolerate statin treatment because of muscular problems","volume":"57","author":"Sinzinger","year":"2004","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2017.01.018_bb0155","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.ejps.2007.12.009","article-title":"Statin induced myotoxicity: the lactone forms are more potent than the acid forms in human skeletal muscle cells in vitro","volume":"33","author":"Skottheim","year":"2008","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2017.01.018_bb0160","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1016\/j.jacc.2013.11.002","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"Stone","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejps.2017.01.018_bb0165","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.trsl.2014.01.013","article-title":"Translational insight into statin-induced muscle toxicity: from cell culture to clinical studies","volume":"164","author":"Taha","year":"2014","journal-title":"Transl. Res."},{"key":"10.1016\/j.ejps.2017.01.018_bb0170","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.trsl.2016.03.015","article-title":"The role of acid-base imbalance in statin-induced myotoxicity","volume":"174","author":"Taha","year":"2016","journal-title":"Transl. Res."},{"key":"10.1016\/j.ejps.2017.01.018_bb0175","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1172\/JCI111883","article-title":"Bovine milk lipoprotein lipase transfers tocopherol to human fibroblasts during triglyceride hydrolysis in vitro","volume":"75","author":"Traber","year":"1985","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejps.2017.01.018_bb0180","doi-asserted-by":"crossref","first-page":"217","DOI":"10.4103\/0972-5229.60175","article-title":"Extreme metabolic alkalosis in intensive care","volume":"13","author":"Tripathy","year":"2009","journal-title":"Indian J. Crit. Care Med."},{"key":"10.1016\/j.ejps.2017.01.018_bb0185","doi-asserted-by":"crossref","first-page":"E271","DOI":"10.1152\/ajpendo.90920.2008","article-title":"Lipoprotein lipase: from gene to obesity","volume":"297","author":"Wang","year":"2009","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.ejps.2017.01.018_bb0190","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1021\/js970407a","article-title":"Role of plasma lipoproteins in modifying the biological activity of hydrophobic drugs","volume":"87","author":"Wasan","year":"1998","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2017.01.018_bb0195","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1093\/clinids\/24.1.78","article-title":"Enhanced amphotericin B nephrotoxicity in intensive care patients with elevated levels of low-density lipoprotein cholesterol","volume":"24","author":"Wasan","year":"1997","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejps.2017.01.018_bb0200","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/nrd2353","article-title":"Impact of lipoproteins on the biological activity and disposition of hydrophobic drugs: implications for drug discovery","volume":"7","author":"Wasan","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejps.2017.01.018_bb0205","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1177\/003693308603100408","article-title":"Survival from extreme lactic and keto-acidosis in diabetes-mellitus","volume":"31","author":"Wathen","year":"1986","journal-title":"Scott. Med. J."},{"key":"10.1016\/j.ejps.2017.01.018_bb0210","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1136\/pgmj.65.763.321","article-title":"Severe, self-limiting lactic acidosis and rhabdomyolysis accompanying convulsions","volume":"65","author":"Winocour","year":"1989","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.ejps.2017.01.018_bb0215","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1211\/0022357021778312","article-title":"In-vitro distribution of terbinafine in rat and human blood","volume":"54","author":"Yeganeh","year":"2002","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejps.2017.01.018_bb0220","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1194\/jlr.M600301-JLR200","article-title":"Effects of lipoprotein lipase and statins on cholesterol uptake into heart and skeletal muscle","volume":"48","author":"Yokoyama","year":"2007","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ejps.2017.01.018_bb0225","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4155\/bio.13.298","article-title":"New US FDA draft guidance on bioanalytical method validation versus current FDA and EMA guidelines: chromatographic methods and ISR","volume":"6","author":"Zimmer","year":"2014","journal-title":"Bioanalysis"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098717300301?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098717300301?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,21]],"date-time":"2022-07-21T21:24:27Z","timestamp":1658438667000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098717300301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":45,"alternative-id":["S0928098717300301"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2017.01.018","relation":{},"ISSN":["0928-0987"],"issn-type":[{"type":"print","value":"0928-0987"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyperlipidaemia alone and in combination with acidosis can increase the incidence and severity of statin-induced myotoxicity","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2017.01.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}